指南与共识脑血管病

入院至溶栓时间延迟的原因及其对治疗时间和结局的影响:Get With The Guidelines-Stroke 研究

Delays in Door-to-Needle Times and Their Impact on Treatment Time and Outcomes in Get With The Guidelines-Stroke.
指南 / 共识 · Stroke · 2017-02-22

该研究分析2012年10月至2015年4月参与Get With The Guidelines-Stroke的1422家医院中55 296例接受静脉阿替普酶溶栓的急性缺血性卒中患者,排除转运及院内卒中。50.2%患者在60分钟内溶栓,31.5%超过60分钟且有记录延迟原因。记录延迟与院内死亡(OR 1.2,95%CI 1.1-1.3)和症状性颅内出血(OR 1.2,95%CI 1.1-1.3)风险升高相关。

要点

  • 近半数患者入院至溶栓时间超过60分钟,其中31.5%有明确延迟原因记录。
  • 诊断延迟使入院至溶栓时间延长36分钟,低血糖或癫痫使时间延长34分钟。
  • 记录延迟与院内死亡和症状性颅内出血风险升高相关。

核心结论

  • 医院层面和 eligibility 延迟(如诊断延迟、无法确定 eligibility)与更长的入院至溶栓时间相关。
  • 改善卒中识别和急性合并症管理可能有助于缩短入院至溶栓时间。

研究设计与样本

  • 回顾性分析 Get With The Guidelines-Stroke 注册研究,纳入2012年10月至2015年4月1422家医院中55 296例接受静脉阿替普酶治疗的急性缺血性卒中患者,排除转运患者和院内卒中。

主要发现

  • 27 778例(50.2%)在60分钟内接受治疗,10 086例(18.2%)超过60分钟但无记录延迟,17 432例(31.5%)超过60分钟且有一项或多项记录延迟原因。
  • 诊断延迟与入院至溶栓时间延长36分钟相关(与无诊断延迟者相比)。
  • 低血糖或癫痫与入院至溶栓时间延长34分钟相关(与无这些情况者相比)。
  • 记录延迟与院内死亡风险升高相关(OR 1.2,95%CI 1.1-1.3)。
  • 记录延迟与症状性颅内出血风险升高相关(OR 1.2,95%CI 1.1-1.3)。

临床怎么用

  • 应关注并记录入院至溶栓时间延迟的原因,尤其是诊断延迟和 eligibility 不确定。
  • 加强卒中识别和急性合并症(如低血糖、癫痫)管理以缩短入院至溶栓时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Despite quality improvement programs such as the American Heart Association/American Stroke Association Target Stroke initiative, a substantial portion of acute ischemic stroke patients are still treated with tissue-type plasminogen activator (alteplase) later than 60 minutes from arrival. This study aims to describe the documented reasons for delays and the associations between reasons for delays and patient outcomes. METHODS: We analyzed the characteristics of 55 296 patients who received intravenous alteplase in 1422 hospitals participating in Get With The Guidelines-Stroke from October 2012 to April 2015, excluding transferred patients and inpatient strokes. We assessed eligibility, medical, and hospital reasons for delays in door-to-needle time. RESULTS: There were 27 778 patients (50.2%) treated within 60 minutes, 10 086 patients (18.2%) treated >60 minutes without documented delays, and 17 432 patients (31.5%) treated >60 minutes with one or more documented reasons for delay. Delayed door-to-needle times were associated with delayed diagnosis (36 minutes longer than those without delay in diagnosis) and hypoglycemia or seizure (34 minutes longer than without those conditions). The presence of documented delays was associated with higher odds of in-hospital mortality (odds ratio, 1.2; 95% confidence interval, 1.1-1.3) and symptomatic intracranial hemorrhage (odds ratio, 1.2; 95% confidence interval, 1.1-1.3) and lower odds of independent ambulation at discharge (odds ratio, 0.92; 95% confidence interval, 0.9-1.0) after adjusting for patient and hospital characteristics. CONCLUSIONS: Hospital and eligibility delays such as delay diagnosis and inability to determine eligibility were associated with longer door-to-needle times. Improved stroke recognition and management of acute comorbidities may help to reduce door-to-needle times.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Kamal N, Sheng S, Xian Y, et al. Delays in Door-to-Needle Times and Their Impact on Treatment Time and Outcomes in Get With The Guidelines-Stroke. Stroke. 2017. PMID: 28228574. doi:10.1161/STROKEAHA.116.015712

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。